Pedro M. Godinez

Pedro Godinez serves as a Contracting Officer responsible for managing the acquisition of pharmaceutical preparations under federal procurement regulations. In this role, he ensures compliance with statutory requirements, executes competitive solicitations, and administers contracts to support critical public health objectives. His procurement activities center on the development, manufacturing, and delivery of finished pharmaceutical products, aligning with agency missions that require reliable, high-quality medicinal supplies. He handles full-cycle acquisitions—from market research and requirement definition to contract award and performance monitoring—often utilizing FAR Part 15 procedures for complex, high-risk procurements. While no specific contractor relationships are currently identifiable in the data, Godinez engages with a broad spectrum of manufacturers and suppliers qualified under cGMP standards, including both large-scale pharmaceutical producers and niche contract development and manufacturing organizations (CDMOs). His working relationships emphasize technical capability, regulatory compliance, and supply chain resilience, with a preference for vendors demonstrating robust quality systems and FDA-registered facilities. Godinez’s procurement portfolio reflects a 100% preference for non-set-aside acquisitions, indicating a focus on open competition rather than socioeconomic set-asides such as 8(a), HUBZone, or SDVOSB programs. This approach prioritizes broad market access and technical suitability over socioeconomic targeting, consistent with the specialized nature of pharmaceutical manufacturing where scale, expertise, and regulatory alignment often outweigh size-based preferences. His primary NAICS specialization is 325412 (Pharmaceutical Preparation Manufacturing), reflecting deep expertise in procuring finished dosage forms such as tablets, capsules, injectables, and sterile solutions. He evaluates technical specifications related to active pharmaceutical ingredients (API) incorporation, stability testing, packaging integrity, and cold chain logistics, ensuring acquired products meet stringent FDA and USP standards. His domain knowledge encompasses GMP compliance, batch release protocols, and supply chain traceability systems critical to pharmaceutical procurement integrity.